Keyphrases
Poly(ADP-ribose) Polymerase
100%
PARP Inhibitor (PARPi)
100%
Heart Failure
100%
Doxorubicin
100%
PJ34
57%
Oxidative Stress
28%
Cardiac Dysfunction
28%
Cardiotoxicity
28%
DNA Damage
14%
Pharmacological Inhibitors
14%
Genomic Deletion
14%
Tissue Injury
14%
Balb C Mice
14%
Protective Effect
14%
Antitumor
14%
Multiple Injections
14%
Left Ventricular Function
14%
Cell Dysfunction
14%
Creatine Kinase Activity
14%
Dual Approach
14%
Doxorubicin Treatments
14%
Cardiac Complications
14%
Anthracycline Antibiotics
14%
Metalloproteinases
14%
Phenanthridinones
14%
Doxorubicin-induced Cardiotoxicity
14%
Similarity Experiment
14%
Serum Lactate Dehydrogenase
14%
Pharmacology, Toxicology and Pharmaceutical Science
Congestive Heart Failure
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase
100%
Doxorubicin
100%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase 1
55%
N (5,6 Dihydro 6 Oxo 2 Phenanthridinyl) 2 Dimethylaminoacetamide
44%
Cardiotoxicity
33%
Nicotinamide Adenine Dinucleotide Adenosine Diphosphate Ribosyltransferase Inhibitor
22%
Tissue Injury
11%
Bagg Albino Mouse
11%
Oxidizing Agent
11%
Metalloproteinase
11%
Creatine Kinase
11%
Anthracycline Antibiotic Agent
11%
Lactate Dehydrogenase
11%